Corlu Alper, Choe Regine, Durduran Turgut, Rosen Mark A, Schweiger Martin, Arridge Simon R, Schnall Mitchell D, Yodh Arjun G
Opt Express. 2007 May 28;15(11):6696-716. doi: 10.1364/oe.15.006696.
We present three-dimensional (3D) in vivo images of human breast cancer based on fluorescence diffuse optical tomography (FDOT). To our knowledge, this work represents the first reported 3D fluorescence tomography of human breast cancer in vivo. In our protocol, the fluorophore Indocyanine Green (ICG) is injected intravenously. Fluorescence excitation and detection are accomplished in the soft-compression, parallel-plane, transmission geometry using laser sources at 786 nm and spectrally filtered CCD detection. Phantom and in vivo studies confirm the signals are due to ICG fluorescence, rather than tissue autofluorescence and excitation light leakage. Fluorescence images of breast tumors were in good agreement with those of MRI, and with DOT based on endogenous contrast. Tumorto- normal tissue contrast based on ICG fluorescence was two-to-four-fold higher than contrast based on hemoglobin and scattering parameters. In total the measurements demonstrate that FDOT of breast cancer is feasible and promising.
IEEE Trans Med Imaging. 2011-5-31
IEEE Trans Image Process. 2014-6
Proc Natl Acad Sci U S A. 2000-3-14
Recent Results Cancer Res. 2013
RSC Adv. 2023-10-30